Healthcare Triangle (NASDAQ:HCTI) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Healthcare Triangle (NASDAQ:HCTI) from a sell rating to a hold rating in a research report sent to investors on Monday morning.

Healthcare Triangle Stock Performance

Shares of HCTI stock opened at $2.84 on Monday. Healthcare Triangle has a 52-week low of $1.37 and a 52-week high of $473.10. The stock has a market cap of $16.56 million, a price-to-earnings ratio of -0.02 and a beta of 0.88. The firm has a fifty day moving average of $6.10 and a 200-day moving average of $46.71.

Healthcare Triangle (NASDAQ:HCTI) last announced its quarterly earnings data on Thursday, August 14th. The company reported ($0.58) earnings per share (EPS) for the quarter. The firm had revenue of $3.56 million for the quarter.

Hedge Funds Weigh In On Healthcare Triangle

A hedge fund recently bought a new stake in Healthcare Triangle stock. Jane Street Group LLC acquired a new stake in Healthcare Triangle, Inc. (NASDAQ:HCTI) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,201,516 shares of the company’s stock, valued at approximately $33,000. Jane Street Group LLC owned approximately 20.60% of Healthcare Triangle as of its most recent filing with the SEC. 0.33% of the stock is currently owned by institutional investors.

About Healthcare Triangle

Healthcare Triangle, Inc, a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.